APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Allergic Rhinitis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Seasonal Allergic Rhinitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174034350326 December 2025180 pages

Choose your research edition.

Industry ResearchSeasonal Allergic Rhinitis Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Allergic Rhinitis Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Seasonal Allergic Rhinitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Allergic Rhinitis Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Allergic Rhinitis Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Seasonal Allergic Rhinitis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Seasonal Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Seasonal Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Seasonal Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Seasonal Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Seasonal Allergic Rhinitis Drug include Allergy Therapeutics Plc, Faes Farma, S.A., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co., Inc., Shionogi & Co., Ltd., VentiRx Pharmaceuticals, Inc., Pfizer Inc. and Merck & Co., Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Seasonal Allergic Rhinitis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Seasonal Allergic Rhinitis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Seasonal Allergic Rhinitis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Seasonal Allergic Rhinitis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Seasonal Allergic Rhinitis Drug Segment by Company

Allergy Therapeutics Plc

Faes Farma, S.A.

Glenmark Pharmaceuticals Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Shionogi & Co., Ltd.

VentiRx Pharmaceuticals, Inc.

Pfizer Inc.

Merck & Co., Inc.

Seasonal Allergic Rhinitis Drug Segment by Type

VTX-1463

PF-06444753

GSP-301

Others

Seasonal Allergic Rhinitis Drug Segment by Application

Clinic

Hospital

Others

Seasonal Allergic Rhinitis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Allergic Rhinitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Allergic Rhinitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Allergic Rhinitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Seasonal Allergic Rhinitis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Seasonal Allergic Rhinitis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Seasonal Allergic Rhinitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Seasonal Allergic Rhinitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Seasonal Allergic Rhinitis Drug Industry Trends Table 2. Seasonal Allergic Rhinitis Drug Industry Drivers Table 3. Seasonal Allergic Rhinitis Drug Industry Opportunities and Challenges Table 4. Seasonal Allergic Rhinitis Drug Industry Restraints Table 5. Global Seasonal Allergic Rhinitis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Seasonal Allergic Rhinitis Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Manufacturers Table 9. Global Seasonal Allergic Rhinitis Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Seasonal Allergic Rhinitis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Seasonal Allergic Rhinitis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Seasonal Allergic Rhinitis Drug Manufacturers, Product Type & Application Table 13. Global Seasonal Allergic Rhinitis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Seasonal Allergic Rhinitis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of VTX-1463 Table 17. Major Manufacturers of PF-06444753 Table 18. Major Manufacturers of GSP-301 Table 19. Major Manufacturers of Others Table 20. Global Seasonal Allergic Rhinitis Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Seasonal Allergic Rhinitis Drug Sales by Type (2021-2026) & (W Units) Table 22. Global Seasonal Allergic Rhinitis Drug Sales by Type (2027-2032) & (W Units) Table 23. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Type (2021-2026) Table 24. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Type (2027-2032) Table 25. Global Seasonal Allergic Rhinitis Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Seasonal Allergic Rhinitis Drug Revenue by Type (2021-2026) & (W Units) Table 27. Global Seasonal Allergic Rhinitis Drug Revenue by Type (2027-2032) & (W Units) Table 28. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Type (2021-2026) Table 29. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Others Table 33. Global Seasonal Allergic Rhinitis Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Seasonal Allergic Rhinitis Drug Sales by Application (2021-2026) & (W Units) Table 35. Global Seasonal Allergic Rhinitis Drug Sales by Application (2027-2032) & (W Units) Table 36. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Application (2021-2026) Table 37. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Application (2027-2032) Table 38. Global Seasonal Allergic Rhinitis Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Seasonal Allergic Rhinitis Drug Revenue by Application (2021-2026) & (W Units) Table 40. Global Seasonal Allergic Rhinitis Drug Revenue by Application (2027-2032) & (W Units) Table 41. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Application (2021-2026) Table 42. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Application (2027-2032) Table 43. Global Seasonal Allergic Rhinitis Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Seasonal Allergic Rhinitis Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Region (2021-2026) Table 46. Global Seasonal Allergic Rhinitis Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Seasonal Allergic Rhinitis Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Seasonal Allergic Rhinitis Drug Sales by Country (2021-2026) & (W Units) Table 50. North America Seasonal Allergic Rhinitis Drug Sales by Country (2027-2032) & (W Units) Table 51. Europe Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Seasonal Allergic Rhinitis Drug Sales by Country (2021-2026) & (W Units) Table 53. Europe Seasonal Allergic Rhinitis Drug Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Seasonal Allergic Rhinitis Drug Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Seasonal Allergic Rhinitis Drug Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales by Country (2027-2032) & (W Units) Table 60. Global Seasonal Allergic Rhinitis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Seasonal Allergic Rhinitis Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Seasonal Allergic Rhinitis Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Region (2021-2026) Table 64. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Region (2027-2032) Table 65. Allergy Therapeutics Plc Company Information Table 66. Allergy Therapeutics Plc Business Overview Table 67. Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Product Portfolio Table 69. Allergy Therapeutics Plc Recent Development Table 70. Faes Farma, S.A. Company Information Table 71. Faes Farma, S.A. Business Overview Table 72. Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Product Portfolio Table 74. Faes Farma, S.A. Recent Development Table 75. Glenmark Pharmaceuticals Ltd. Company Information Table 76. Glenmark Pharmaceuticals Ltd. Business Overview Table 77. Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio Table 79. Glenmark Pharmaceuticals Ltd. Recent Development Table 80. Hisamitsu Pharmaceutical Co., Inc. Company Information Table 81. Hisamitsu Pharmaceutical Co., Inc. Business Overview Table 82. Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio Table 84. Hisamitsu Pharmaceutical Co., Inc. Recent Development Table 85. Shionogi & Co., Ltd. Company Information Table 86. Shionogi & Co., Ltd. Business Overview Table 87. Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio Table 89. Shionogi & Co., Ltd. Recent Development Table 90. VentiRx Pharmaceuticals, Inc. Company Information Table 91. VentiRx Pharmaceuticals, Inc. Business Overview Table 92. VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Product Portfolio Table 94. VentiRx Pharmaceuticals, Inc. Recent Development Table 95. Pfizer Inc. Company Information Table 96. Pfizer Inc. Business Overview Table 97. Pfizer Inc. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pfizer Inc. Seasonal Allergic Rhinitis Drug Product Portfolio Table 99. Pfizer Inc. Recent Development Table 100. Merck & Co., Inc. Company Information Table 101. Merck & Co., Inc. Business Overview Table 102. Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio Table 104. Merck & Co., Inc. Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Seasonal Allergic Rhinitis Drug Distributors List Table 108. Seasonal Allergic Rhinitis Drug Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Seasonal Allergic Rhinitis Drug Product Image Figure 2. Global Seasonal Allergic Rhinitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasonal Allergic Rhinitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Seasonal Allergic Rhinitis Drug Sales (2021-2032) & (W Units) Figure 5. Global Seasonal Allergic Rhinitis Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Seasonal Allergic Rhinitis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. VTX-1463 Image Figure 9. PF-06444753 Image Figure 10. GSP-301 Image Figure 11. Others Image Figure 12. Global Seasonal Allergic Rhinitis Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Seasonal Allergic Rhinitis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Type (2021-2032) Figure 15. Global Seasonal Allergic Rhinitis Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Seasonal Allergic Rhinitis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Others Image Figure 21. Global Seasonal Allergic Rhinitis Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Seasonal Allergic Rhinitis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Seasonal Allergic Rhinitis Drug Sales Market Share by Application (2021-2032) Figure 24. Global Seasonal Allergic Rhinitis Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Seasonal Allergic Rhinitis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Seasonal Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Seasonal Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Seasonal Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 41. China Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Seasonal Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Seasonal Allergic Rhinitis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Seasonal Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Seasonal Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Seasonal Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Seasonal Allergic Rhinitis Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Seasonal Allergic Rhinitis Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • VTX-1463
  • PF-06444753
  • GSP-301
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Allergy Therapeutics Plc
  • Faes Farma, S.A.
  • Glenmark Pharmaceuticals Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Shionogi & Co., Ltd.
  • VentiRx Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Seasonal Allergic Rhinitis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Seasonal Allergic Rhinitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Seasonal Allergic Rhinitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Seasonal Allergic Rhinitis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Seasonal Allergic Rhinitis Drug Market Dynamics
  1. 2.1 Seasonal Allergic Rhinitis Drug Industry Trends
  2. 2.2 Seasonal Allergic Rhinitis Drug Industry Drivers
  3. 2.3 Seasonal Allergic Rhinitis Drug Industry Opportunities and Challenges
  4. 2.4 Seasonal Allergic Rhinitis Drug Industry Restraints
3 Seasonal Allergic Rhinitis Drug Market by Manufacturers
  1. 3.1 Global Seasonal Allergic Rhinitis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Seasonal Allergic Rhinitis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Seasonal Allergic Rhinitis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Seasonal Allergic Rhinitis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Seasonal Allergic Rhinitis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Seasonal Allergic Rhinitis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Seasonal Allergic Rhinitis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Seasonal Allergic Rhinitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Seasonal Allergic Rhinitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Seasonal Allergic Rhinitis Drug Tier 1, Tier 2, and Tier 3
4 Seasonal Allergic Rhinitis Drug Market by Type
  1. 4.1 Seasonal Allergic Rhinitis Drug Type Introduction
  2. 4.1.1 VTX-1463
  3. 4.1.2 PF-06444753
  4. 4.1.3 GSP-301
  5. 4.1.4 Others
  6. 4.2 Global Seasonal Allergic Rhinitis Drug Sales by Type
  7. 4.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Seasonal Allergic Rhinitis Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Seasonal Allergic Rhinitis Drug Revenue by Type
  11. 4.3.1 Global Seasonal Allergic Rhinitis Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Seasonal Allergic Rhinitis Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Type (2021-2032)
5 Seasonal Allergic Rhinitis Drug Market by Application
  1. 5.1 Seasonal Allergic Rhinitis Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Seasonal Allergic Rhinitis Drug Sales by Application
  6. 5.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Seasonal Allergic Rhinitis Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Seasonal Allergic Rhinitis Drug Revenue by Application
  10. 5.3.1 Global Seasonal Allergic Rhinitis Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Seasonal Allergic Rhinitis Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Application (2021-2032)
6 Global Seasonal Allergic Rhinitis Drug Sales by Region
  1. 6.1 Global Seasonal Allergic Rhinitis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Seasonal Allergic Rhinitis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Seasonal Allergic Rhinitis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Seasonal Allergic Rhinitis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Seasonal Allergic Rhinitis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Seasonal Allergic Rhinitis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Seasonal Allergic Rhinitis Drug Revenue by Region
  1. 7.1 Global Seasonal Allergic Rhinitis Drug Revenue by Region
  2. 7.1.1 Global Seasonal Allergic Rhinitis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Seasonal Allergic Rhinitis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Seasonal Allergic Rhinitis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Seasonal Allergic Rhinitis Drug Revenue (2021-2032)
  8. 7.2.2 North America Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Seasonal Allergic Rhinitis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Seasonal Allergic Rhinitis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Seasonal Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergy Therapeutics Plc
  2. 8.1.1 Allergy Therapeutics Plc Company Information
  3. 8.1.2 Allergy Therapeutics Plc Business Overview
  4. 8.1.3 Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Product Portfolio
  6. 8.1.5 Allergy Therapeutics Plc Recent Developments
  7. 8.2 Faes Farma, S.A.
  8. 8.2.1 Faes Farma, S.A. Company Information
  9. 8.2.2 Faes Farma, S.A. Business Overview
  10. 8.2.3 Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Product Portfolio
  12. 8.2.5 Faes Farma, S.A. Recent Developments
  13. 8.3 Glenmark Pharmaceuticals Ltd.
  14. 8.3.1 Glenmark Pharmaceuticals Ltd. Company Information
  15. 8.3.2 Glenmark Pharmaceuticals Ltd. Business Overview
  16. 8.3.3 Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio
  18. 8.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments
  19. 8.4 Hisamitsu Pharmaceutical Co., Inc.
  20. 8.4.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
  21. 8.4.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
  22. 8.4.3 Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
  24. 8.4.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments
  25. 8.5 Shionogi & Co., Ltd.
  26. 8.5.1 Shionogi & Co., Ltd. Company Information
  27. 8.5.2 Shionogi & Co., Ltd. Business Overview
  28. 8.5.3 Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio
  30. 8.5.5 Shionogi & Co., Ltd. Recent Developments
  31. 8.6 VentiRx Pharmaceuticals, Inc.
  32. 8.6.1 VentiRx Pharmaceuticals, Inc. Company Information
  33. 8.6.2 VentiRx Pharmaceuticals, Inc. Business Overview
  34. 8.6.3 VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
  36. 8.6.5 VentiRx Pharmaceuticals, Inc. Recent Developments
  37. 8.7 Pfizer Inc.
  38. 8.7.1 Pfizer Inc. Company Information
  39. 8.7.2 Pfizer Inc. Business Overview
  40. 8.7.3 Pfizer Inc. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
  42. 8.7.5 Pfizer Inc. Recent Developments
  43. 8.8 Merck & Co., Inc.
  44. 8.8.1 Merck & Co., Inc. Company Information
  45. 8.8.2 Merck & Co., Inc. Business Overview
  46. 8.8.3 Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
  48. 8.8.5 Merck & Co., Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Seasonal Allergic Rhinitis Drug Value Chain Analysis
  2. 9.1.1 Seasonal Allergic Rhinitis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Seasonal Allergic Rhinitis Drug Production Mode & Process
  6. 9.2 Seasonal Allergic Rhinitis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Seasonal Allergic Rhinitis Drug Distributors
  9. 9.2.3 Seasonal Allergic Rhinitis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst